Mother-to-child transmission of human immunodeficiency virus type 1: Influence of parity and mode of delivery
- 31 Downloads
In a national prospective study of risk factors for mother-tochild transmission of human immunodeficiency virus (HIV), 316 children of HIV-positive mothers were followed up for at least 6 months. Infection status was determined in 254 of them and 46 were found to be infected giving a transmission rate of 18.1%. Univariate analysis of potential risk factors for mother-to-child transmission showed an association between primiparity and increased transmission rate: odds ratio 2.2, 95% confidence interval (CI) 1.1–4.6,P<0.05. Analysis by logistic regression confirmed this association (adjusted odds ratio 2.4) and showed, in addition, a negative association between transmission rate and elective Caesarean section (adjusted odds ratio 0.36, 95% CI 0.13–0.97,P<0.05). The effect of primiparity was less pronounced in combination with elective Caesarean section (odds ratio 1.7) than with other delivery modes (odds ratio 2.5, difference not significant. HIV-infected children were less likely to experience the birth of a younger sibling during the observation period than their uninfected counterparts (2 of 46 vs 27 of 208,P<0.05 by logrank test).
Primiparous women appear to transmit HIV to their children at a higher rate. This could be explained by increased intrapartum transmission because of longer and more complicated labour in primiparas and/or by a self-selection of women with lower risk of transmission among those deciding to have additional children.
Key wordsHIV infections Infant newborn Pregnancy Parity Caesarean section
human immunodeficiency virus type 1
Unable to display preview. Download preview PDF.
- 1.Centres for Disease Control (1986) Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 35: 334–339Google Scholar
- 2.Centres for Disease Control (1994) Recommendations of the U.S. public health service task force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 43/RR-11: 1–20Google Scholar
- 3.Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy J-F, Culnane M, Coombs R, Elkins M, Moye MS, Stratton P, Balsley J, for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331: 1173–1180PubMedGoogle Scholar
- 4.Cox DR, Oakes D (1984) Analysis of survival data. Chapman and Hall, LondonGoogle Scholar
- 5.Dunn D, Newell ML, Mayaux MJ, Kind C, Hutto C, Goedert JJ, Andiman W, Perinatal AIDS Collaborative Transmission Studies (1994) Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J-Acquir Immune Def Syn 7: 1064–1066Google Scholar
- 6.Kind C, Brändle B, Wyler C-A, Calame A, Rudin C, Schaad UB, Schüpbach J, Senn H-P, Perrin L, Matter L, the Swiss Neonatal HIV Study Group (1992) Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Eur J Pediatr 151: 442–448PubMedGoogle Scholar
- 7.Kind C (1994) HIV-Übertragung von der infizierten Mutter auf ihr Kind. Hans Huber, Bern, pp 68–79Google Scholar
- 10.Newell ML, Peckham C (1993) Risk factors for vertical transmission of HIV-1. AIDS 7 [Suppl 1]: S91-S97Google Scholar
- 11.Pädiatrische AIDS-Gruppe Schweiz (PAGS), Kommission der Schweizerischen Gesellschaft für Pädiatrie, Subkommission Klinik (SKK) der Eidgenössischen Kommission für AIDS-Fragen (EKAF), Arbeitsgruppe HIV der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe (1994) Zidovudin zur Prophylaxe der HIV-Übertragung von der infizierten Mutter auf ihr Kind. Schweiz Ärztezeitung 75: 1508–1509Google Scholar
- 12.Rothman KJ (1986) Modern epidemiology. Little, Brown and Co, BostonGoogle Scholar
- 14.The European Collaborative Study (1994) Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 343: 1464–1467Google Scholar